Abstract:Background: Chemicals are not required to be tested systematically for their neurotoxic potency, although they may contribute to the development of several neurological diseases. The absence of systematic testing may be partially explained by the current Organisation for Economic Co-operation and Development (OECD) Test Guidelines, which rely on animal experiments that are expensive, laborious, and ethically debatable. Therefore, it is important to understand the risks to exposed workers and the general population exposed to domestic products. In this study, we propose a strategy to test the neurotoxicity of solvents using the commonly used glycol ethers as a case study. Objective: This study aims to provide a strategy that can be used by regulatory agencies and industries to rank solvents according to their neurotoxicity and demonstrate the use of toxicokinetic modeling to predict air concentrations of solvents that are below the no observed adverse effect concentrations (NOAECs) for human neurotoxicity determined in in vitro assays. Methods: The proposed strategy focuses on a complex 3D in vitro brain model (BrainSpheres) derived from human-induced pluripotent stem cells (hiPSCs). This model is accompanied by in vivo, in vitro, and in silico models for the blood-brain barrier (BBB) and in vitro models for liver metabolism. The data are integrated into a toxicokinetic model. Internal concentrations predicted using this toxicokinetic model are compared with the results from in vivo human-controlled exposure experiments for model validation. The toxicokinetic model is then used in reverse dosimetry to predict air concentrations, leading to brain concentrations lower than the NOAECs determined in the hiPSC-derived 3D brain model. These predictions will contribute to the protection of exposed workers and the general population with domestic exposures. Results: The Swiss Centre for Applied Human Toxicology funded the project, commencing in January 2021. The Human Ethics Committee approval was obtained on November 16, 2022. Zebrafish experiments and in vitro methods started in February 2021, whereas recruitment of human volunteers started in 2022 after the COVID-19 pandemic-related restrictions were lifted. We anticipate that we will be able to provide a neurotoxicity testing strategy by 2026 and predicted air concentrations for 6 commonly used propylene glycol ethers based on toxicokinetic models incorporating liver metabolism, BBB leakage parameters, and brain toxicity. Conclusions: This study will be of great interest to regulatory agencies and chemical industries needing and seeking novel solutions to develop human chemical risk assessments. It will contribute to protecting human health from the deleterious effects of environmental chemicals. International registered report identifier (irrid): DERR1-10.2196/50300.

Intuitive toxicology in the 21st century—Bridging the perspectives of the public and risk assessors in Europe

Public views of animal testing and alternatives in chemical risk assessment

Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience

Alternative methods go green! Green toxicology as a sustainable approach for assessing chemical safety and designing safer chemicals

New approach methodologies in human regulatory toxicology - Not if, but how and when!

Consensus report on the future of animal-free systemic toxicity testing

The probable future of toxicology - probabilistic risk assessment

An ecotoxicological view on neurotoxicity assessment

A critical review on the toxicological and epidemiological evidence integration for assessing human health risks to environmental chemical exposures

Alternative approaches to vertebrate ecotoxicity tests in the 21st century: A review of developments over the last 2 decades and current status

Role of model organisms and nanocompounds in human health risk assessment

A Twin Transition in Regulatory Toxicology-moving towards Chemicals 2.0 and phasing out animal testing

A quantitative screening-level approach to incorporate chemical exposure and risk into alternative assessment evaluations

Transforming Toxicity Assessment through Microphysiology, Bioprinting, and Computational Modeling

Chemicals regulation and non-animal methods: displacing the gold standard

Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies

High-throughput screening paradigms in ecotoxicity testing: Emerging prospects and ongoing challenges

Trans-disciplinary diagnosis for an in-depth reform of regulatory expertise in the field of environmental toxicology and security

Novel Strategy to Assess the Neurotoxicity of Organic Solvents Such as Glycol Ethers: Protocol for Combining In Vitro and In Silico Methods With Human-Controlled Exposure Experiments

Use of new scientific developments in regulatory risk assessments: challenges and opportunities

Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment